Search details
1.
Multiorgan failure caused by pembrolizumab and axitinib in a woman affected by metastatic clear cell renal cell carcinoma: A case report and literature review.
Medicine (Baltimore)
; 103(13): e37606, 2024 Mar 29.
Article
in English
| MEDLINE | ID: mdl-38552059
2.
Neutrophil-to-Eosinophil Ratio Predicts the Efficacy of Avelumab in Patients With Advanced Urothelial Carcinoma Enrolled in the MALVA Study (Meet-URO 25).
Clin Genitourin Cancer
; 22(4): 102099, 2024 Apr 24.
Article
in English
| MEDLINE | ID: mdl-38776583
3.
Prognostic role of systemic inflammation indexes in metastatic urothelial carcinoma treated with immunotherapy.
Future Sci OA
; 9(7): FSO878, 2023 Aug.
Article
in English
| MEDLINE | ID: mdl-37485441
4.
Liver Metastases of Unknown Primary Renal Cell Carcinoma Treated With Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors: A Case Report and Literature Review.
Anticancer Res
; 43(5): 2359-2365, 2023 May.
Article
in English
| MEDLINE | ID: mdl-37097698
5.
Advanced Non-Clear Cell Renal Cell Carcinoma Treatments and Survival: A Real-World Single-Centre Experience.
Cancers (Basel)
; 15(17)2023 Aug 31.
Article
in English
| MEDLINE | ID: mdl-37686629
6.
The prognostic Value of Thyroid Hormone Levels in Immunotherapy-Treated Patients With Metastatic Urothelial Carcinoma.
Clin Genitourin Cancer
; 21(5): e378-e385, 2023 10.
Article
in English
| MEDLINE | ID: mdl-37164813
7.
Geographical differences in the management of metastatic de novo renal cell carcinoma in the era of immune-combinations.
Minerva Urol Nephrol
; 75(4): 460-470, 2023 Aug.
Article
in English
| MEDLINE | ID: mdl-37530662
8.
Nivolumab drug holiday in patients treated for metastatic renal cell carcinoma: A real-world, single-centre experience.
Front Oncol
; 12: 960751, 2022.
Article
in English
| MEDLINE | ID: mdl-36033511
Results
1 -
8
de 8
1
Next >
>>